Drug Companies Continue Breaking Law, Even After Being Fined $11 Billion
Over the past 3 years, pharmaceutical companies have been fined a record $11 billion for unethical and illegal practices.
Kevin Outterson, a Professor of Law at Boston University, who compiled the data on all the major violations, told Russia Today that the companies are unlikely to change and see the fines as “the cost of doing business.”
According to Outterson, eight out of the ten biggest pharmaceutical companies in the world have been caught breaking the law over the past three years.
GlaxoSmithKline covered up clinical studies and intimidated researchers who discovered that their diabetes drug, Avandia, significantly increased the risk of heart attacks, reports Russia Today .
GlaxoSmithKline did not withdraw Avandia, but continued to promote it.
GlaxoSmithKline's Wellbutrin was sold to doctors as a “happy, horny, skinny drug,” to be prescribed for anything from obesity to sexual dysfunction, but in reality the drug had only been approved for treating depression.
Johnson & Johnson, paid tens of millions of dollars in kickbacks to Omnicare which would supply Risperdal to its nursing homes for treating dementia. However, Risperdal was not approved to treat dementia.